Latest Press Releases

Health News Posted on Friday, July 25, 2025

Premium Press Releases »

First half of 2025: Solid growth, Investments and Pipeline Progress Pave the Way for Two Key Launches in H2

Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion) Regulatory submissions underway for zongertinib and nerandomilast, with launches expected in H2 2025 Strategic ...

Read More

Best Things to Do with Friends in 2025 - Ideas for Fun, Bonding & Games

Things to Do with Friends: Making Every Hangout Unforgettable July 2025 In an era where digital distractions often replace real interaction, finding meaningful and fun things to do with friends has never been more important. Whether you're ...

Read More

How to Choose the Best Term Insurance Plan Based on Your Life Stage

Choosing the best term insurance plan can be an important part of your financial journey. But the plan that works for someone in their 20s may not work for someone in their 50s. That’s because our needs keep changing as we grow older. A young ...

Read More

Press Releases »

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

PR Newswire LAS VEGAS, July 24, 2025 The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of rheumatoid ...

Read More
Advertisement

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

PR Newswire LAS VEGAS, July 24, 2025 The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of the B7-H4 biomarker, and ...

Read More

LeadingAge partners with ICAA for Active Aging Week 2025: Celebrating the contributions and spirit of older adults

PR Newswire VANCOUVER, BC, July 24, 2025 The International Council on Active Aging® (ICAA) has announced a new partnership with LeadingAge to expand the reach of Active Aging Week 2025, presented by Humana. Taking place October 6–12, this ...

Read More

LUNGevity Foundation Joins 2025 LungXperience Tour to Promote Lung Health and Early Detection Across the U.S.

PR Newswire WASHINGTON, July 24, 2025 Organization to Participate in 12 National Events as Part of Innovative Health Education Initiative WASHINGTON, July 24, 2025 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung ...

Read More
Advertisement

Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer

PR Newswire HONG KONG, July 23, 2025 HONG KONG, July 23, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical ...

Read More

Happy Docs Make Happy Patients

PR Newswire ST. LOUIS, July 23, 2025 AI technology boosts face-to-face time with patients, earns Mercy national recognition for physician satisfaction ST. LOUIS, July 23, 2025 /PRNewswire/ -- Mercy's strategic and carefully planned use ...

Read More

Scaling Self-Care Can Be a Game-Changer in Global Fight Against Non-Communicable Diseases

PR Newswire GENEVA, July 24, 2025 GENEVA, July 24, 2025 /PRNewswire/ -- On International Self-Care Day, and as world leaders prepare for a landmark United Nations General Assembly meeting on non-communicable diseases (NCDs) this September, ...

Read More

Hillhurst Biopharmaceuticals Doses First Subject in Phase 2a Clinical Trial of HBI-002, a Novel Therapy for Sickle Cell Disease

PR Newswire SAN DIEGO, July 23, 2025 SAN DIEGO, July 23, 2025 /PRNewswire/ -- Hillhurst Biopharmaceuticals Inc. ("Hillhurst"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products based on known ...

Read More

Blenrep (belantamab mafodotin) combinations approved in Canada for the treatment of relapsed/refractory multiple myeloma

Canada NewsWire MISSISSAUGA, ON, July 23, 2025 MISSISSAUGA, ON, July 23, 2025 /CNW/ - GSK announced today that Health Canada has approved Blenrep (belantamab mafodotin for injection) in combination with bortezomib and dexamethasone, or in ...

Read More

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

PR Newswire FRANKLIN LAKES, N.J., July 23, 2025 FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...

Read More

Health In Tech Donates 60 Computers to Diocese of Srikakulam to Empower Education and Community Development

PR Newswire STUART, Fla., July 23, 2025 STUART, Fla., July 23, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce its donation of 60 new computers to ...

Read More

Apnimed Reports Positive Topline Results from Second Phase 3 Trial of AD109, Reinforcing Potential of First Oral Pill for Obstructive Sleep Apnea

PR Newswire CAMBRIDGE, Mass., July 23, 2025 CAMBRIDGE, Mass., July 23, 2025 /PRNewswire/ -- Apnimed, Inc., a pharmaceutical company advancing an industry-leading pipeline of first-in-class oral therapies that address the root causes of ...

Read More

Landmark Trial Demonstrates Efficacy of Microcurrent Therapy in Heart Failure: C-MIC II Results Published in the European Journal of Heart Failure

PR Newswire ZUG, Switzerland, July 23, 2025 ZUG, Switzerland, July 23, 2025 /PRNewswire/ -- Berlin Heals and the C-MIC II Investigators today announced the publication of the C-MIC II trial results in the European Journal of Heart Failure. ...

Read More

Best Things to Do with Friends in 2025 - Ideas for Fun, Bonding & Games

Things to Do with Friends: Making Every Hangout Unforgettable July 2025 In an era where digital distractions often replace real interaction, finding meaningful and fun things to do with friends has never been more important. Whether you're ...

Read More

How to Choose the Best Term Insurance Plan Based on Your Life Stage

Choosing the best term insurance plan can be an important part of your financial journey. But the plan that works for someone in their 20s may not work for someone in their 50s. That’s because our needs keep changing as we grow older. A young ...

Read More

Taiho Oncology and Cullinan Therapeutics Announce Acceptance of Abstracts for Zipalertinib at the IASLC 2025 World Conference on Lung Cancer

PR Newswire PRINCETON, N.J. and CAMBRIDGE, Mass., July 22, 2025 PRINCETON, N.J. and CAMBRIDGE, Mass., July 22, 2025 /PRNewswire/ -- Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., today announced the presentation of new data from ...

Read More

Summer Pitch: How to Prevent Baseball Injuries This Season

PR Newswire ROSEMONT, Ill., July 21, 2025 The American Academy of Orthopaedic Surgeons share expert tips to help players stay safe on the field ROSEMONT, Ill., July 21, 2025 /PRNewswire/ -- Baseball and softball are cherished summer ...

Read More

Marine, Mom of Four, Pastry Chef Among Five Winners in Life Time's First-Ever 60XT Wellness Challenge

PR Newswire CHANHASSEN, Minn., July 21, 2025 Grand prize winners each take home $25,000 in prizes  CHANHASSEN, Minn., July 21, 2025 /PRNewswire/ -- Life Time (NYSE: LTH), the nation's premier healthy lifestyle brand, today revealed ...

Read More

AusperBio Receives China CDE Clearance to Advance AHB-137 into Phase III Clinical Trial for Chronic Hepatitis B

PR Newswire SAN FRANCISCO, July 21, 2025 SAN FRANCISCO, July 21, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted ...

Read More

Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Platinum Sensitive Ovarian Cancer

PR Newswire HOLON, Israel, July 21, 2025 HOLON, Israel, July 21, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered ...

Read More

Nuvalent Announces Initiation of ALKAZAR Phase 3 Randomized, Controlled Trial Evaluating Neladalkib for Patients with TKI-naïve ALK-positive NSCLC

PR Newswire CAMBRIDGE, Mass., July 21, 2025 CAMBRIDGE, Mass., July 21, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven ...

Read More

Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1

PR Newswire DUBLIN, July 21, 2025 – Alixorexton Demonstrated Clinically Meaningful and Statistically Significant Improvements in Wakefulness at All Doses Tested Compared to Placebo in Patients With Narcolepsy Type 1 – – Alixorexton ...

Read More

Canadians agree: fixing health care will help build stronger Canada

Canada NewsWire HUNTSVILLE, ON, July 21, 2025 HUNTSVILLE, ON, July 21, 2025 /CNW/ - The Canadian Medical Association (CMA) is heading to Muskoka this week to remind Canada's leaders of the important role health care can play in building a ...

Read More

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

PR Newswire AUSTIN, Texas, July 21, 2025 AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an ...

Read More

10 Benefits of a Medical Cannabis Card You Need to Know

The Hidden Perks of Having a Medical Cannabis Card Most People Miss According to a survey of 2024, over 3 million people in the U.S. hold a medical cannabis card. Most people think it is only to access cannabis for medical purposes. But in ...

Read More

Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Cleveland, Tennessee

PR Newswire BIRMINGHAM, Ala. and CLEVELAND, Tenn., July 18, 2025 BIRMINGHAM, Ala. and CLEVELAND, Tenn., July 18, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 40-bed inpatient ...

Read More

The American College of Surgeons Advances New Clinical Data Strategy to Improve Surgical Care for Patients

PR Newswire CHICAGO, July 18, 2025 Collaboration with Epic is first phase of a multiyear project that will include multiple technology partners CHICAGO, July 18, 2025 /PRNewswire/ -- Long recognized as a leader in the use of rigorously ...

Read More

Helping families get ahead with a more generous Canada Child Benefit

Canada NewsWire PETERBOROUGH, ON, July 18, 2025 PETERBOROUGH, ON, July 18, 2025 /CNW/ - As families raising children across the country receive the Canada Child Benefit (CCB) today, the Honourable Anna Gainey, Secretary of State (Children ...

Read More

Cure HHT Leads Global Breakthrough in Bleeding Standards, Paving the Way for Future HHT Therapies

PR Newswire MONKTON, Md., July 18, 2025 Cure HHT has led the development of the first international consensus on how to define, measure, and track bleeding in Hereditary Hemorrhagic Telangiectasia (HHT), published July 15 in the American ...

Read More

Boostaro Reviews (Complaints & Consumer Reports) Can It Really Boost Blood Flow In Men or Over Hype?

What You'll Get in This Article What Boostaro is and how it supports men's health A breakdown of its key natural ingredients and their benefits How the formula works to improve blood flow, energy, and mood The main health advantages of ...

Read More
More Press Releases